J M Edelman

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi request reprint Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group
    J M Edelman
    Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    Ann Intern Med 132:97-104. 2000
  2. ncbi request reprint Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
    R A Baumgartner
    Merck Research Laboratories, Merck and Co, Inc, Rahway, NJ 007065 1900, USA
    Eur Respir J 21:123-8. 2003

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group
    J M Edelman
    Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    Ann Intern Med 132:97-104. 2000
    ..Montelukast, an oral, once-daily leukotriene receptor antagonist, provides protection against exercise-induced bronchoconstriction...
  2. ncbi request reprint Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
    R A Baumgartner
    Merck Research Laboratories, Merck and Co, Inc, Rahway, NJ 007065 1900, USA
    Eur Respir J 21:123-8. 2003
    ....